Inventor · disambiguated record
Yusuke Ogitani
Also filed as: OGITANI YUSUKE
12 granted patents·4 pending applications·176 citations·filing 2013–2024
91Inventor score
Files withDAIICHI SANKYO CO LTD16
Top patents by PatentIndex Score
16 records- 0197US10729782B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2017·Granted Aug 4, 2020·18 cites·13 claims
- 0297US9808537B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Nov 7, 2017·44 cites·18 claims
- 0396US10973924B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Apr 13, 2021·9 cites·2 claims
- 0496US10195288B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2013·Granted Feb 5, 2019·43 cites·35 claims
- 0595US10155821B2Anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2016·Granted Dec 18, 2018·17 cites·8 claims
- 0695US9872924B2Antibody-drug conjugate produced by binding through linker having hydrophilic structureDAIICHI SANKYO CO LTD·Filed 2013·Granted Jan 23, 2018·36 cites·47 claims
- 0793US11795236B2Method for treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2018·Granted Oct 24, 2023·6 cites·12 claims
- 0893US11584800B2Method of treating cancer comprising administration of anti-HER2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Feb 21, 2023·2 cites·7 claims
- 0989US2025049782A1Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2024·Application pending·0 cites
- 1087US12186310B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Granted Jan 7, 2025·0 cites·1 claims
- 1185US11633493B2Antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2020·Granted Apr 25, 2023·1 cites·14 claims
- 1283US2024026030A1Method of treating cancer comprising administration of anti-her2 antibody-drug conjugateDAIICHI SANKYO CO LTD·Filed 2023·Application pending·0 cites
- 1355US2022023436A1Combination of antibody-drug conjugate with parp inhibitorDAIICHI SANKYO CO LTD·Filed 2019·Application pending·0 cites
- 1449US12497465B2Combination of antibody-drug conjugate and tubulin inhibitorDAIICHI SANKYO CO LTD·Filed 2019·Granted Dec 16, 2025·0 cites·47 claims
- 1538US11185594B2(Anti-HER2 antibody)-drug conjugateDAIICHI SANKYO CO LTD·Filed 2015·Granted Nov 30, 2021·0 cites·11 claims
- 1635US2019330368A1Therapy for drug-resistant cancer by administration of anti-her2 antibody/drug conjugateDAIICHI SANKYO CO LTD·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yusuke Ogitani files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →